CMS issues new drug rules to save $17B

The Centers for Medicare & Medicaid Services (CMS) has issued new rules expected to cut Medicaid spending on drugs by about $17.7 billion over the next five years, according to Bloomberg. The savings will be achieved primarily from shifting more costs to pharmaceutical manufacturers and pharmacies. The new rule "puts in place simple measures that will cut costs, increase transparency and benefit consumers," CMS acting administrator Marilyn Tavenner said in a press release Friday. Statement

Suggested Articles

With the promotion of Don Trigg, Cerner has named its first new president since 2018.

ONC head Donald Rucker, M.D. said Wednesday that regulators are trying to strike a balance between privacy and transparency with upcoming rule.

Here's a look at the performance.